微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 6.49% | -15.27% | 39.27% | 55/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.66% | -13.54% | 85.66% | 40/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.51% | -9.39% | -69.65% | 48/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 8.27% | -22.49% | 7.96% | 38/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.66% | -13.35% | 42.12% | 43/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.39% | -8.18% | 94.58% | 38/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.77% | -57.32% | -74.04% | 42/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 10.67% | -35.95% | 20.7% | 43/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.84% | -18.53% | 50.6% | 38/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.87% | -22.25% | -9.55% | 37/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 6.49% | 150.58% | -61.04% | 3/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.66% | -39.09% | 53.55% | 18/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 10.85% | 82.66% | 43.71% | 28/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 7.55% | -54.08% | -72.39% | 29/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 27.35% | 171.33% | 66.36% | 7/160 | 3.74% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 16.44% | 205.58% | 63.1% | 6/160 | 4.24% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 10.08% | -33.11% | 69.7% | 58/160 | 2.78% | 汇宇制药 | 55.94% | 行业排名> |
| 2019-09-30 | 5.94% | 2% | 10.41% | 60/160 | 7.61% | 河化股份 | 45.32% | 行业排名> |
| 2019-06-30 | 5.38% | 2% | 107.72% | 44/160 | 5.05% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-03-31 | 2.59% | 2% | -82.81% | 43/160 | 2.46% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 15.07% | 2% | 2% | 31/160 | 7.09% | 奥赛康 | 35% | 行业排名> |